Lipe & Dalton’s Brookfield BN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.02M Sell
164,830
-3,806
-2% -$170K 3.26% 6
2026
Q1
$6.83M Sell
168,636
-350
-0.2% -$15.5K 3.57% 6
2025
Q4
$7.75M Sell
168,986
-3,864
-2% -$176K 3.83% 5
2025
Q3
$7.9M Sell
172,850
-7,738
-4% -$343K 3.92% 5
2025
Q2
$7.45M Sell
180,588
-5,204
-3% -$193K 4.02% 4
2025
Q1
$6.49M Sell
185,792
-4,861
-3% -$184K 3.63% 4
2024
Q4
$7.3M Sell
190,653
-438
-0.2% -$16.5K 3.87% 5
2024
Q3
$6.77M Sell
191,091
-405
-0.2% -$12.8K 3.42% 5
2024
Q2
$5.3M Sell
191,496
-6,170
-3% -$172K 2.85% 8
2024
Q1
$5.52M Buy
197,666
+161
+0.1% +$4.34K 2.84% 10
2023
Q4
$5.28M Hold
197,505
2.87% 10
2023
Q3
$4.12M Sell
197,505
-299
-0.2% -$6.74K 2.48% 12
2023
Q2
$4.44M Sell
197,804
-1,786
-0.9% -$37.9K 2.53% 11
2023
Q1
$4.34M Sell
199,590
-4,892
-2% -$110K 2.48% 13
2022
Q4
$4.29M Sell
204,482
-50,373
-20% -$1.13M 2.47% 15
2022
Q3
$5.62M Sell
254,855
-180
-0.1% -$4.66K 3.52% 5
2022
Q2
$6.11M Sell
255,035
-345
-0.1% -$9.22K 3.58% 4
2022
Q1
$7.79M Sell
255,380
-4,767
-2% -$143K 3.8% 3
2021
Q4
$8.46M Buy
260,147
+1,277
+0.5% +$40.4K 4% 3
2021
Q3
$7.46M Sell
258,870
-1,945
-0.7% -$56.8K 3.84% 5
2021
Q2
$7.17M Sell
260,815
-983
-0.4% -$25.2K 3.73% 4
2021
Q1
$6.24M Sell
261,798
-5,803
-2% -$129K 3.46% 6
2020
Q4
$5.91M Sell
267,601
-634
-0.2% -$12.7K 3.63% 3
2020
Q3
$4.75M Sell
268,235
-183
-0.1% -$3.27K 3.3% 6
2020
Q2
$4.73M Sell
268,418
-2,458
-0.9% -$43.2K 3.43% 4
2020
Q1
$4.28M Sell
270,876
-5,908
-2% -$122K 3.62% 4
2019
Q4
$5.71M Sell
276,784
-2,943
-1% -$58.7K 3.78% 4
2019
Q3
$5.3M Sell
279,727
-6,477
-2% -$117K 3.87% 3
2019
Q2
$4.88M Sell
286,204
-2,096
-0.7% -$35.5K 3.49% 7
2019
Q1
$4.8M Sell
288,300
-381
-0.1% -$5.93K 3.53% 7
2018
Q4
$3.95M Sell
288,681
-1,962
-0.7% -$29.3K 3.22% 10
2018
Q3
$4.62M Buy
290,643
+12,679
+5% +$193K 3.15% 11
2018
Q2
$4.02M Buy
277,964
+1,368
+0.5% +$19.5K 2.96% 13
2018
Q1
$3.85M Buy
276,596
+1,191
+0.4% +$17.2K 2.75% 15
2017
Q4
$4.28M Sell
275,405
-1,934
-0.7% -$29.2K 2.96% 13
2017
Q3
$4.09M Buy
277,339
+765
+0.3% +$10.7K 2.87% 14
2017
Q2
$3.87M Buy
276,574
+1,242
+0.5% +$16.7K 2.51% 14
2017
Q1
$3.58M Sell
275,332
-5,126
-2% -$65K 2.59% 16
2016
Q4
$3.3M Sell
280,458
-1,051
-0.4% -$12.8K 2.35% 19
2016
Q3
$3.53M Sell
281,509
-1,399
-0.5% -$17.1K 2.37% 17
2016
Q2
$3.34M Sell
282,908
-159,366
-36% -$1.91M 2.3% 17
2016
Q1
$5.4M Sell
442,274
-7,364
-2% -$79.3K 4.25% 3
2015
Q4
$4.98M Sell
449,638
-6,635
-1% -$77.8K 4.03% 5
2015
Q3
$5.04M Sell
456,273
-14,745
-3% -$172K 4.18% 2
2015
Q2
$5.78M Sell
471,018
-20,232
-4% -$258K 4.14% 2
2015
Q1
$6.17M Buy
+491,250
New +$6.09M 4.25% 2

Other funds holding BN

Lipe & Dalton's BN Position: Q2 2026 in Review

Lipe & Dalton reduced its Brookfield (BN) stake by 2.3% in Q2 2026, selling an estimated $170K and leaving 164,830 shares worth $7.02M. The position accounts for 3.26% of the portfolio, ranked #6.

Lipe & Dalton first reported a position in BN in Q1 2015 and has held it in 46 quarters since. The position peaked at $8.46M in Q4 2021. 940 funds tracked by Wall St. Rank hold BN as of Q2 2026.

  • Lipe & Dalton held 164,830 shares of Brookfield worth $7.02M as of Q2 2026.
  • Lipe & Dalton sold 3,806 Brookfield shares in Q2 2026, an estimated $170K.
  • Brookfield made up 3.26% of Lipe & Dalton's portfolio in Q2 2026, its #6 holding.
  • Lipe & Dalton first reported a position in Brookfield in Q1 2015 and has held it in 46 quarters since.
  • Lipe & Dalton's Brookfield position peaked at $8.46M in Q4 2021.
  • 940 funds tracked by Wall St. Rank held Brookfield as of Q2 2026.

Based on Lipe & Dalton's 13F filing for Q2 2026, filed 14 Jul 2026.